These final results, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 guidance the strategy of concentrating on ACKR3 as a singular way to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated disorders. (2) The physician https://hermannt738mcs3.wikibyby.com/user